⚠ Evidence note: An aging clock is a statistical model, not a measurement of aging itself; predictive validity varies widely between clocks and populations.
Alzheimer’s Early Detection and Diagnosis
Current understanding
To be populated as evidence accumulates.
Evidence log
- 2026-11-14 — Association between Brain Amyloid Status and Cognitive and Physical Performance in Older Adults with Frailty Criteria: Longitudinal Data from the CogFrail Study.: [human-observational] Two-year longitudinal CogFrail data in cognitively impaired prefrail and frail older adults linked brain amyloid positivity to faster cognitive decline but found no association with accelerated physical-performance decline or loss of independence, supporting outcome-specific prognostic relevance without establishing causation or excluding longer-term functional associations. [human-observational] (novelty: 3)
- 2026-10-23 — Loneliness relates to smaller hippocampal subfield volumes in individuals with elevated plasma pTau217: results from IGNITE.: [human-observational] IGNITE observational analysis in cognitively unimpaired older adults linked loneliness to smaller CA3 and entorhinal cortex volumes specifically among those with elevated plasma pTau217, without establishing causation, prediction of future cognitive decline, or added diagnostic accuracy. [human-observational] (novelty: 3)
- 2026-11-02 — Visual, hearing, and dual sensory impairment and risk of dementia: The role of social isolation, depressive symptoms, and cognitive function.: cross-connection with intrinsic-capacity: [human-observational] The UK Biobank cohort links objective sensory deficits overlapping the IC sensory domain to subsequent dementia risk, connecting functional assessment with dementia-risk research without establishing Alzheimer’s-specific diagnostic accuracy or causal mediation. (novelty: 3)
- 2026-10-30 — An Exceptional Mobility Group Among Older Adults: Protocol for the Super Movers Study.: [human-observational] Super Movers prospective cohort protocol proposes investigating biomarkers of preserved motor and cognitive function in fast-walking adults aged 80+, without yet establishing prospective cognitive-risk prediction or Alzheimer’s-specific diagnostic validity. [human-observational] (novelty: 3)
- 2026-11-02 — Joint associations of handgrip strength and chair-stand performance with motoric cognitive risk syndrome in older adults.: [human-observational] Observational study in older adults linked combined handgrip weakness and impaired chair-stand performance to over ninefold higher odds of motoric cognitive risk syndrome, an association that does not establish Alzheimer’s-specific diagnostic validity or prediction of future dementia. [human-observational] (novelty: 3)
- 2026-10-15 — Beyond Usual Pace: Quick Walking Speed and Brain Health Outcomes in the Framingham Heart Study.: [human-observational] Framingham Heart Study observational analysis linked quick walking speed and gait adaptability to 10-year incident dementia and executive dysfunction beyond the signal captured by usual walking speed, extending functional risk-marker evidence without establishing Alzheimer’s-specific diagnostic validity. [human-observational] (novelty: 3)
- 2026-10-13 — Regional oxygen extraction fraction is higher in older adults with type 2 diabetes and obesity: associations with cognition and metabolic markers.: Human observational pilot study found elevated QSM MRI-derived cerebral oxygen extraction fraction in older adults with co-occurring type 2 diabetes and obesity, associated with worse executive function and altered adipokine levels, but did not establish Alzheimer’s-specific diagnostic validity or prediction of future cognitive decline. [human-observational] [human-observational] (novelty: 3)
- 2026-10-07 — Large Language Model-Based Identification of Subjective Cognitive Decline in Electronic Health Records Among Older Adults With Normal Cognitive Testing: Retrospective Cohort Study.: Retrospective cohort applying a validated 2-stage LLM pipeline to EHRs identified documented cognitive concerns consistent with SCD in 13.8% of older adults with normal cognitive testing, with documentation uncommon and selectively associated with clinical/sociodemographic factors — advances EHR-based SCD phenotyping as a scalable early-detection signal but also surfaces documentation-equity gaps. [human-observational] (novelty: 3)
- 2025-09-12 — Prevalence of Subjective Cognitive Decline Among Older Multiracial Adults, 2019-2023.: BRFSS 2019-2023 analysis estimates adjusted subjective cognitive decline prevalence at 16.0% among U.S. Multiracial adults ≥45 — among the highest of any racial group and ~2× that of Asian adults — flagging a surveillance and inclusion gap for self-reported SCD as an early-detection signal in understudied populations. [human-observational] (novelty: 3)
- 2026-10-01 — Study design and results of the Wave VI Add Health Cognitive Assessment, Physical, and Sensory Function (Add CAPS) protocol.: Add Health Wave VI Add CAPS protocol establishes a nationally representative early-midlife (mean ~44) cognitive, physical, and sensory battery intended to enable longitudinal Alzheimer’s trajectory research decades before most aging-cohort baselines; descriptive methods paper, no biomarker or diagnostic performance data yet. [human-observational] (novelty: 3)
- 2026-08-02 — Brain aging clocks: From methodological advances to cellular mechanisms.: Brain aging clocks review argues multi-modal, cellular-resolution brain-age models could support earlier prediction and targeted intervention for neurodegenerative disease via senescence-linked mechanisms; expert synthesis, not a validated diagnostic. [expert-opinion] (novelty: 3)
- 2025-11-16 — Association of tongue, handgrip, and pinch strength with blood-based phosphorylated-tau 181 in cognitively healthy older adults.: Cross-sectional study in cognitively healthy older adults found handgrip (in those ≥69) and pinch strength inversely associated with plasma p-tau181, while tongue strength was not — extends grip-based functional prescreens to a specific plasma AD biomarker rather than composite cognitive outcomes. [human-observational] (novelty: 3)
- 2025-12-15 — Sensorimotor function as an early marker of cognitive decline and alzheimer’s biomarker burden.: Observational cohort in cognitively normal older adults links slower gait speed to higher CSF tau/Aβ burden and plasma NfL, and shows gait/grip predict cognitive trajectory — supports sensorimotor measures as cheap prescreens aligning with molecular AD biomarkers. [human-observational] (novelty: 3)
- 2026-05-30 — Development of Machine Learning-Driven Dual-Task Gait Test Model for Cognitive Impairment Screening.: Community-dwelling cohort (adults ≥60) ML dual-task gait model reported AUC 0.883 for dementia and 0.895 for cognitive impairment screening, with gait speed and stride variability as top predictors — a scalable primary-care prescreen candidate, but single-cohort development data without external validation. [human-observational] (novelty: 3)
- 2026-09-14 — #407 ‒ Preventing cardiovascular and Alzheimer’s disease: lowering LDL early, APOE4, and promising new therapies | Michael Davidson, M.D.: Peter Attia Drive #407 with Michael Davidson frames APOE4 carrier status plus early LDL/ApoB trajectory as a dual CVD/AD risk-stratification lens, positioning lipid biology as an upstream input to Alzheimer’s early-detection workups; expert-media claim, no new cohort data. [expert-opinion] (novelty: 3)
- 2026-09-16 — Sex-specific biological aging clocks across organs and omics.: Sex-specific organ-system aging clocks showed distinct female vs male preclinical Alzheimer’s cognitive trajectories that sex-pooled clock models flattened — suggests sex-stratified organ-clock readouts could add resolution to preclinical AD risk stratification, but observational and not yet validated as a diagnostic tool. [human-observational] (novelty: 4)
- 2026-09-14 — APOE:RAAS epistasis as a population specific risk factor for cognitive impairment and cardiovascular health.: HABS-HD cohort epistasis analysis found APOE×RAAS gene-gene interactions associated with cognitive-impairment risk in population-specific patterns across African American, Mexican American, and non-Hispanic White groups, stratified by APOE ε4 status — suggests genetic risk-stratification for early detection may need ancestry-specific interaction models rather than APOE ε4 alone. [human-observational] (novelty: 3)
- 2026-09-12 — The Pin1-cis P-tau Axis: A Key Common Early Pathogenic Driver, Biomarker and Therapeutic Target Across Neurodegenerative, Traumatic, and Vascular Cognitive Disorders.: Review-level synthesis positions cis P-tau (upstream of tangles, downstream of Pin1 inactivation) as a shared early biomarker candidate across AD, TBI, and vascular cognitive disorders — narrative consolidation, not new cohort validation. [expert-opinion] (novelty: 3)
- 2026-09-26 — Plasma and cerebrospinal fluid proteomics reveal distinct patterns of senescence and neuropathology in aging rhesus macaques.: Aging rhesus macaque study finds CSF proteomic signatures of early neuropathology and geriatric subclusters that partially mirror human AD-associated proteins, supporting NHPs as a preclinical substrate for developing CSF-based early-detection panels — animal-model evidence, not a human diagnostic validation. [animal-model] (novelty: 3)
- 2026-09-21 — Plasma inflammatory markers and brain white matter microstructure in late middle-aged and older adults.: Cross-sectional dementia-free cohort (n=457) found plasma inflammatory markers (cytokines, CRP, GFAP) correlated with white-matter microstructure independently of plasma AD biomarkers — suggests inflammation-related brain injury signal that is orthogonal to Aβ/tau-based early-detection workups. [human-observational] (novelty: 3)
- 2026-09-19 — Alzheimer’s disease biomarkers in relation to non-cognitive domains within the intrinsic capacity framework: a narrative review.: Narrative review (119 studies) argues non-cognitive functional domains (gait, grip, mood, hearing) associate with AD biomarkers and could serve as low-cost prescreens or complementary signals to Aβ/tau/NfL workups; synthesis only, no new primary data. [human-observational] (novelty: 3)
- 2026-09-11 — Gait speed and neurocognitive disorders: a comprehensive systematic review and meta-analysis.: Meta-analysis (40 studies) supports gait speed — both cross-sectional slow gait (HR 1.47) and longitudinal decline (≥0.05 m/s decrement, HR 2.01) — as a low-cost functional prescreen for dementia and cognitive impairment, complementing biomarker and imaging workups. [human-observational] (novelty: 3)
- 2026-08-13 — Essentials: How to Optimize Female Hormone Health for Vitality & Longevity | Dr. Sara Gottfried: Huberman Lab Essentials with Sara Gottfried invokes perimenopausal brain hypometabolism as an early, sex-specific window for cognitive-decline risk stratification in women, positioning hormone-transition biomarkers as candidate early-detection signals alongside conventional AD workups; podcast expert claim, no new imaging or cohort data. [expert-opinion] (novelty: 3)
- 2026-07-13 — #399 ‒ The evolution of Alzheimer’s disease and dementia care: how early detection, personalized treatment, new therapies, and a multimodal approach are changing the landscape | Gayatri Devi, M.D.: Podcast interview (Peter Attia Drive #399) with neurologist Gayatri Devi arguing that early AD diagnosis now meaningfully alters trajectory when combined with new anti-amyloid therapies and multimodal care; clinician opinion, no new primary data. [expert-opinion] (novelty: 3)
Open questions
Related
Contributing findings
Association between Brain Amyloid Status and Cognitive and Physical Performance in Older Adults with Frailty Criteria: Longitudinal Data from the CogFrail Study.
14-nov-2026
novelty 3
per-area 3
strengthens
Neural Mechanisms of Cognitive Assessment and Rehabilitation for Cognitive Decline
13-nov-2026
novelty 2
per-area 2
mentions
HOme-based Brain Monitoring With a GARment-EEG to Study Cognitive Decline in the Aging Population
13-nov-2026
novelty 2
per-area 2
strengthens
Computerized Tests of Cognitive Decline in Presymptomatic Alzheimer's Disease
13-nov-2026
novelty 2
per-area 2
strengthens
Metabolic syndrome and Alzheimer's disease: Mechanistic links and precision prevention (Review).
13-nov-2026
novelty 2
per-area 2
mentions
Safety and Modulation of ABCC9 Pathways by Nicorandil for the Treatment of Hippocampal Sclerosis of Aging
10-nov-2026
novelty 3
per-area 2
mentions
Evidence for Cerebrospinal Fluid Flow Through the Brain to Stagnate in Alzheimer's Disease
10-nov-2026
novelty 2
per-area 2
mentions
Mindfulness Meditation to Reduce Cognitive Load
09-nov-2026
novelty 2
per-area 2
strengthens
Joint associations of handgrip strength and chair-stand performance with motoric cognitive risk syndrome in older adults.
02-nov-2026
novelty 3
per-area 3
strengthens
Postural adjustments in standing and gait reflect amnestic mild cognitive impairment.
02-nov-2026
novelty 2
per-area 2
strengthens
An Exceptional Mobility Group Among Older Adults: Protocol for the Super Movers Study.
30-oct-2026
novelty 3
per-area 3
strengthens
Loneliness relates to smaller hippocampal subfield volumes in individuals with elevated plasma pTau217: results from IGNITE.
23-oct-2026
novelty 3
per-area 3
strengthens
Beyond Usual Pace: Quick Walking Speed and Brain Health Outcomes in the Framingham Heart Study.
15-oct-2026
novelty 3
per-area 3
strengthens
Regional oxygen extraction fraction is higher in older adults with type 2 diabetes and obesity: associations with cognition and metabolic markers.
13-oct-2026
novelty 3
per-area 3
strengthens
Large Language Model-Based Identification of Subjective Cognitive Decline in Electronic Health Records Among Older Adults With Normal Cognitive Testing: Retrospective Cohort Study.
07-oct-2026
novelty 3
per-area 3
strengthens
Study design and results of the Wave VI Add Health Cognitive Assessment, Physical, and Sensory Function (Add CAPS) protocol.
01-oct-2026
novelty 3
per-area 3
strengthens
Systemic inflammation, gut microbiome composition, and cognitive performance among older Ugandans with Alzheimer's disease and related dementias: A cross-sectional study.
01-oct-2026
novelty 2
per-area 2
mentions
Association between peripheral platelet markers and motoric cognitive risk syndrome: a cross-sectional analysis of data from the WCHAT study.
01-oct-2026
novelty 2
per-area 2
mentions
The end of Alzheimer’s?
30-sep-2026
novelty 2
per-area 2
mentions
Disease Modifying Potential of 5mg of Melatonin on Cognition and Brain Health in Aging
28-sep-2026
novelty 2
per-area 2
mentions
Plasma and cerebrospinal fluid proteomics reveal distinct patterns of senescence and neuropathology in aging rhesus macaques.
26-sep-2026
novelty 3
per-area 3
strengthens
An intestine-centric view of neurodegeneration: How intestine-derived signals mediate the intestine-brain axis to impact Alzheimer's disease.
23-sep-2026
novelty 2
per-area 2
mentions
Plasma inflammatory markers and brain white matter microstructure in late middle-aged and older adults.
21-sep-2026
novelty 3
per-area 3
strengthens
Trajectory-Oriented Brain Vulnerability Framework for Cognitive Decline in Type 2 Diabetes.
19-sep-2026
novelty 2
per-area 2
mentions
Alzheimer's disease biomarkers in relation to non-cognitive domains within the intrinsic capacity framework: a narrative review.
19-sep-2026
novelty 3
per-area 3
strengthens
Dementia Risk Registry Across the Multidimensional Lifespan: A 10-Year Study
17-sep-2026
novelty 2
per-area 2
mentions
Sex-specific biological aging clocks across organs and omics.
16-sep-2026
novelty 4
per-area 4
strengthens
#407 ‒ Preventing cardiovascular and Alzheimer’s disease: lowering LDL early, APOE4, and promising new therapies | Michael Davidson, M.D.
14-sep-2026
novelty 3
per-area 3
strengthens
APOE:RAAS epistasis as a population specific risk factor for cognitive impairment and cardiovascular health.
14-sep-2026
novelty 3
per-area 3
strengthens
The Pin1-cis P-tau Axis: A Key Common Early Pathogenic Driver, Biomarker and Therapeutic Target Across Neurodegenerative, Traumatic, and Vascular Cognitive Disorders.
12-sep-2026
novelty 3
per-area 3
strengthens
Dendritic Cell Antigen Presentation Enables T Cells to Enter the Brain and Contribute to Tau Pathology
11-sep-2026
novelty 3
per-area 2
mentions
Gait speed and neurocognitive disorders: a comprehensive systematic review and meta-analysis.
11-sep-2026
novelty 3
per-area 3
strengthens
Amyloid PET Imaging in the Baltimore Longitudinal Study of Aging
10-sep-2026
novelty 2
per-area 2
mentions
Healthy Aging in Neighborhoods of Diversity Across the Life Span (HANDLS)
08-sep-2026
novelty 2
per-area 1
mentions
Rethinking Apathy and Gait: Clinical Implications for Dementia and Integrated Care.
07-sep-2026
novelty 2
per-area 2
strengthens
Microbiome in Aging of Gut and Brain
02-sep-2026
novelty 2
per-area 2
mentions
Enhancing Attention and Wellbeing Using Digital Therapeutics
24-aug-2026
novelty 2
per-area 1
mentions
Aging and Exercise Impacts on Glymphatic Function
20-aug-2026
novelty 2
per-area 2
mentions
Center for Research and Education on Aging and Technology Enhancement - CREATE V - Project 2
17-aug-2026
novelty 2
per-area 3
strengthens
Essentials: How to Optimize Female Hormone Health for Vitality & Longevity | Dr. Sara Gottfried
13-aug-2026
novelty 3
per-area 3
strengthens
A Study To Assess The Feasibility Of Indivi Mobile Application In Monitoring Cognitive Performance In Aging Population
11-aug-2026
novelty 2
per-area 2
introduces
Neuroplasticity Enhancement From Cognitive Training Reinforced by Psilocybin
07-aug-2026
novelty 3
per-area 2
mentions
How do energy metabolism disorders and neuroinflammation collectively contribute to the pathogenesis of Alzheimer's disease?
04-aug-2026
novelty 2
per-area 1
mentions
Brain aging clocks: From methodological advances to cellular mechanisms.
02-aug-2026
novelty 3
per-area 3
strengthens
Gating of somatosensory neural oscillations across the lifespan: A narrative review.
28-jul-2026
novelty 2
per-area 2
mentions
#399 ‒ The evolution of Alzheimer’s disease and dementia care: how early detection, personalized treatment, new therapies, and a multimodal approach are changing the landscape | Gayatri Devi, M.D.
13-jul-2026
novelty 3
per-area 3
strengthens
Suboptimal adherence to brain health recommendations in patients pursuing anti-amyloid antibody therapy for Alzheimer's disease: Report from the Brain Health Vital Signs project.
10-jul-2026
novelty 2
per-area 2
mentions
Olfactory Dysfunction in Aging Adults
22-jun-2026
novelty 2
per-area 2
mentions
Cholinergic Health After Menopause (CHAMP)
12-jun-2026
novelty 2
per-area 2
strengthens
Development of Machine Learning-Driven Dual-Task Gait Test Model for Cognitive Impairment Screening.
30-may-2026
novelty 3
per-area 3
strengthens